Latest Insights & Research

Stay informed with the latest public health research, insights, and evidence-based analysis from our team of experts.

Policy

RFK speaks on Vaccines :-(

As misinformation spreads rampant across the globe, issues surrounding public health and vaccines have come into the spotlight. One of the recent high-profile cases involves the decision by the US government to pull $500 million in funding from mRNA vaccine research. This decision, led by the US Health Secretary, claims that these vaccines offer ‘more […]

Read more →
Global

Addressing Vaccine Inequities and Emerging Infectious Diseases

The global health landscape is being reshaped by various overlapping crises, including ongoing challenges from infectious diseases and the effects of climate change. As we move through 2025, a year marked by significant health concerns, public health leaders and stakeholders are advocating for a comprehensive and collaborative approach to tackle these issues. Vaccine Inequities: A […]

Read more →
News

The Initial Impact of RFK

Robert F. Kennedy Jr. has wasted no time in pursuing his agenda, announcing plans to investigate childhood vaccine schedules and anti-depressant medications as potential drivers of chronic diseases. In a speech to HHS staff, Kennedy urged them to keep an “open mind.” Yet, his past statements and actions raise concerns about the potential erosion of […]

Read more →
photo by Kate Trifo on unsplash
Commentary

Changing the Message to Decrease Vaccine Hesitancy

No bones about it. We’re getting crushed by the Delta variant of COVID-19. Or, more accurately, the unvaccinated are getting crushed by the Delta variant. This has created a cascade of direct consequences. First and foremost, people are dying. But not just dying. Dying unnecessarily. As has been noted, 99% of COVID-related deaths have been […]

Read more →

Get the public-health insights you need—
every Thursday morning.

We scan 70+ journals so you don't have to.
One email. Zero jargon. Unsubscribe anytime.

🔒 No spam. 1-click opt-out. Privacy-first.